Raymond James Financial’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.63M Buy
103,190
+7,809
+8% +$267K ﹤0.01% 3036
2026
Q2
$3.12M Buy
95,381
+3,986
+4% +$118K ﹤0.01% 3145
2026
Q1
$2.65M Sell
91,395
-12,645
-12% -$368K ﹤0.01% 3126
2025
Q4
$2.95M Buy
+104,040
New +$2.83M ﹤0.01% 2944
2025
Q3
– Sell
-7,032
Closed -$149K – 5772
2025
Q2
$149K Buy
+7,032
New +$144K ﹤0.01% 4665
2025
Q1
– Sell
-41,261
Closed -$888K – 4877
2024
Q4
$888K Buy
+41,261
New +$952K ﹤0.01% 3530

Other funds holding IBBQ

Raymond James Financial's IBBQ Position: Q3 2026 in Review

Raymond James Financial increased its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 8.2% in Q3 2026, buying an estimated $267K and bringing the position to 103,190 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3036.

Raymond James Financial first reported a position in IBBQ in Q4 2024 and has held it in 6 quarters since. 45 funds tracked by Wall St. Rank hold IBBQ as of Q3 2026.

  • Raymond James Financial held 103,190 shares of Invesco NASDAQ Biotechnology ETF worth $3.63M as of Q3 2026.
  • Raymond James Financial bought 7,809 Invesco NASDAQ Biotechnology ETF shares in Q3 2026, an estimated $267K.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #3036 holding.
  • Raymond James Financial first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
  • 45 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.